Gene-editing stocks took a big step forward in November when CRISPR Therapeutics (NASDAQ:CRSP) reported fairly positive results from the first patients treated with a CRISPR-based drug. Early success …
More CRISPR Stock Catalysts Ahead
More CRISPR Stock Catalysts Ahead
Leave a reply